Researchers identify new cause of brain defects in tuberous sclerosis patients

February 9, 2017, Rockefeller University Press
Electron microscopy shows that, compared to a mouse lacking neuronal Tsc1 (left), the number of axons wrapped in a myelin sheath is increased in the brain of a mouse that also lacks CTGF (right). Credit: Ercan et al., 2017

Boston Children's Hospital researchers have uncovered a new molecular pathway that inhibits the myelination of neurons in the brains of patients with the rare genetic disorder tuberous sclerosis complex (TSC). The study, "Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex," which will be published online February 9 in The Journal of Experimental Medicine, suggests new ways to treat some of the neurological symptoms associated with TSC, including autism and epilepsy.

TSC is caused by mutations in the genes TSC1 and TSC2. The disease affects approximately 1 in 6,000 people and is characterized by the growth of numerous benign tumors in different tissues of the body, including the brain, skin, eyes, kidneys, heart, and lungs. Many patients also have such as epilepsy, intellectual disability, and autism. Patients' brains show various abnormal structures. In particular, TSC patients with autism show defects in the organization of their , the regions of the brain where oligodendrocyte cells protect neuronal axons by wrapping them in an insulating myelin sheath.

Mustafa Sahin and colleagues previously found that mice whose lack TSC1 fail to myelinate their axons correctly, but the reason for this defect remained unclear. Sahin's team at Boston Children's Hospital and Harvard Medical School now reveal that neurons lacking TSC1 secrete increased amounts of a protein called connective tissue growth factor (CTGF) and that this protein impedes oligodendrocyte development and myelination. Deleting the gene encoding CTGF restored the ability of oligodendrocytes to myelinate axons in mice lacking neuronal TSC1.

Sahin and colleagues found that CTGF levels were also elevated in neurons derived from TSC patients. "Our study provides the first description of a molecular mechanism that could underlie the aberrant white matter microstructure in TSC ," Sahin says. "Future studies of the effects of CTGF on oligodendrocyte development will be a major goal for the discovery of new therapeutic targets."

The researchers add that the role of CTGF secreted from neurons should be investigated in other myelination diseases, including multiple sclerosis and some forms of cerebral palsy.

Explore further: Oligodendrocytes selectively myelinate a particular set of axons in the white matter

More information: The Journal of Experimental Medicine, DOI: 10.1084/jem.20160446

Related Stories

Oligodendrocytes selectively myelinate a particular set of axons in the white matter

October 21, 2016
There are three kinds of glial cells in the brain: oligodendrocytes, astrocytes and microglia. Oligodendrocytes myelinate neuronal axons to increase conduction velocity of neuronal impulses. A Japanese research team at the ...

Impaired recycling of mitochondria in autism?

October 18, 2016
Tuberous sclerosis complex (TSC), a genetic disorder that causes autism in about half of those affected, could stem from a defect in a basic system cells use to recycle their mitochondria, report scientists at Boston Children's ...

Autism may involve disordered white matter in the brain

December 5, 2011
It's still unclear what's different in the brains of people with autism spectrum disorders (ASDs), but evidence from genetic and cell studies points to abnormalities in how brain cells (neurons) connect to each other. A study ...

Deleting a single gene results in autism-like behavior; immunosuppressant drug prevents symptoms

July 2, 2012
Deleting a single gene in the cerebellum of mice can cause key autistic-like symptoms, researchers have found. They also discovered that rapamycin, a commonly used immunosuppressant drug, prevented these symptoms.

Recommended for you

Non-invasive malaria test wins Africa engineering prize

June 24, 2018
Languishing with fever and frustrated by delays in diagnosing his illness, Brian Gitta came up with a bright idea: a malaria test that would not need blood samples or specialized laboratory technicians.

Study reveals new therapeutic target for slowing the spread of flu virus

June 22, 2018
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, Ph.D., ...

First ancient syphilis genomes decoded

June 21, 2018
An international research team, including scientists from the Max Planck Institute for the Science of Human History, the University of Tübingen, the National School of Anthropology and History in Mexico City, and the University ...

Rhesus macaque model offers route to study Zika brain pathology

June 21, 2018
Rhesus macaque monkeys infected in utero with Zika virus develop similar brain pathology to human infants, according to a report by researchers at the California National Primate Research Center and School of Veterinary Medicine ...

California Aedes mosquitoes capable of spreading Zika

June 21, 2018
Over the last five years, Zika virus has emerged as a significant global human health threat following outbreaks in South and Central America. Now, researchers reporting in PLOS Neglected Tropical Diseases have shown that ...

Breakthrough treatment for crippling jaw disease created

June 20, 2018
A first-ever tissue implant to safely treat a common jaw defect, known as temporomandibular joint dysfunction, has been successfully tested by UCI-led researchers in a large animal model, according to new findings.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.